Susquehanna International Group
ZYME icon

Susquehanna International Group’s Zymeworks ZYME Stock Holding History

Susquehanna International Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$854K Sell
34,100
-55,500
-62% -$1.31M ﹤0.01% 8295
2025
Q4 		$2.36M Sell
89,600
-53,100
-37% -$1.16M ﹤0.01% 5301
2025
Q3 		$2.44M Buy
142,700
+88,900
+165% +$1.27M ﹤0.01% 5369
2025
Q2 		$675K Buy
53,800
+43,600
+427% +$519K ﹤0.01% 8465
2025
Q1 		$121K Sell
10,200
-1,400
-12% -$19.1K ﹤0.01% 11402
2024
Q4 		$170K Sell
11,600
-377,900
-97% -$5.28M ﹤0.01% 10908
2024
Q3 		$4.89M Buy
389,500
+298,900
+330% +$3.25M ﹤0.01% 3621
2024
Q2 		$771K Buy
90,600
+58,500
+182% +$521K ﹤0.01% 7195
2024
Q1 		$338K Sell
32,100
-14,500
-31% -$161K ﹤0.01% 9441
2023
Q4 		$484K Sell
46,600
-7,300
-14% -$58.2K ﹤0.01% 8739
2023
Q3 		$342K Sell
53,900
-14,500
-21% -$107K ﹤0.01% 9074
2023
Q2 		$591K Buy
68,400
+13,800
+25% +$124K ﹤0.01% 7913
2023
Q1 		$494K Sell
54,600
-54,500
-50% -$475K ﹤0.01% 8596
2022
Q4 		$858K Buy
109,100
+75,800
+228% +$533K ﹤0.01% 6525
2022
Q3 		$205K Sell
33,300
-126,600
-79% -$763K ﹤0.01% 10777
2022
Q2 		$847K Buy
159,900
+112,700
+239% +$682K ﹤0.01% 6930
2022
Q1 		$309K Sell
47,200
-20,600
-30% -$184K ﹤0.01% 10206
2021
Q4 		$1.11M Sell
67,800
-5,500
-8% -$115K ﹤0.01% 7023
2021
Q3 		$2.13M Sell
73,300
-37,900
-34% -$1.26M ﹤0.01% 5692
2021
Q2 		$3.86M Buy
111,200
+35,500
+47% +$1.13M ﹤0.01% 4514
2021
Q1 		$2.39M Sell
75,700
-23,700
-24% -$963K ﹤0.01% 5479
2020
Q4 		$4.7M Buy
99,400
+7,100
+8% +$330K ﹤0.01% 3497
2020
Q3 		$4.3M Buy
92,300
+9,300
+11% +$319K ﹤0.01% 3265
2020
Q2 		$2.99M Buy
83,000
+3,300
+4% +$122K ﹤0.01% 3807
2020
Q1 		$2.83M Sell
79,700
-7,800
-9% -$319K ﹤0.01% 3388
2019
Q4 		$3.98M Buy
87,500
+60,700
+226% +$2.21M ﹤0.01% 3303
2019
Q3 		$665K Sell
26,800
-2,200
-8% -$55.1K ﹤0.01% 6637
2019
Q2 		$638K Buy
+29,000
New +$532K ﹤0.01% 6740

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group's ZYME Position: Q1 2026 in Review

Susquehanna International Group reduced its Zymeworks (ZYME) stake by 86% in Q1 2026, selling an estimated $3.59M and leaving 24,421 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #9139.

Susquehanna International Group first reported a position in ZYME in Q4 2018 and has held it in 26 quarters since. The position peaked at $4.64M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Susquehanna International Group held 24,421 shares of Zymeworks worth $612K as of Q1 2026.
  • Susquehanna International Group sold 151,667 Zymeworks shares in Q1 2026, an estimated $3.59M.
  • Zymeworks made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9139 holding.
  • Susquehanna International Group first reported a position in Zymeworks in Q4 2018 and has held it in 26 quarters since.
  • Susquehanna International Group's Zymeworks position peaked at $4.64M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.